With a more than 30-year history of research and knowledge, Adesis’ mission is to accelerate our clients’ success through innovative chemistry and solutions from discovery to market.
Adesis Inc. – a subsidiary of Universal Display Corporation (Nasdaq: OLED), a global leader in organic light emitting diodes – is a premier contract development and manufacturing organization (CDMO) accelerating our clients’ success by bringing the innovation of a clean technology company to the biotech, pharmaceutical and specialty chemical industries.
Our innovative capabilities enable technology you use every day, ranging from OLED smartwatches, smartphones, automotive, IT and TVs to foldable electronic devices, lighting, medical devices and pharmaceutical breakthroughs.
Serving as an extension of our clients’ R&D departments and/or project teams.
Instilling a corporate focus on client satisfaction by meeting our clients’ requirements and goals of reducing their time to market through Discovery, Process, Development and Manufacturing.
Developing deep relationships with our clients to drive satisfaction, seek opportunities for continuous improvement, and forge long-lasting partnerships.
Adesis operates under a certified ISO 9001 quality management system (QMS). This internationally recognized standard demonstrates our shared dedication to exceptional client centricity, quality, efficiency, and continuous improvement.
Our business model provides clients with organic chemistry services in three areas: early-stage discovery research, non-GMP scale-up and process development, and specialty manufacturing. We specialize in organic and organometallic synthesis, from milligrams to multi-kilogram quantities. We are known for our expertise in heterocycles, deuteration and high purity monomers – just to name a few areas – and our exceptional team takes pride in our ability to innovate and solve challenging chemistry problems for our rapidly growing client base.
Adesis encompasses approximately 100,000 sq ft of state-of-the-art laboratory, manufacturing, and client services space in two U.S. locations – New Castle and Wilmington, DE – centrally located in the Mid-Atlantic biotech/pharma hub.
Our Mission
Accelerate our clients’ success through innovative chemistry and solutions from discovery to market.
Our Vision
Innovate for Life.
Our Values
Innovation:
Advance the Line: We are innovators and explorers, pushing boundaries and innovating with quality and speed.
Ownership:
Act with Ownership: We are accountable and personally invested in being the best for our clients and colleagues.
Integrity:
Achieve with Integrity: We are honest, transparent, respectful, and live up to our commitments.
1991
Dr. Chuck Beard forms CB Research
Product line includes UV blockers and an extensive catalog of heterocyclic compounds
2008
First lab expansion in New Castle to 25,000 sq ft
2017
Adesis opens new laboratory facility at Delaware Innovation Space in the DuPont Experimental Station
2020
With safety measures in place, Adesis meets customer commitments through the pandemic
2005
Adesis forms and acquires the assets of CB Research
2016
UDC acquires Adesis
2018
Adesis further expands New Castle labs to 50,000 sq ft
2022
Adesis expands at DuPont Experimental Station to >40,000 sq ft, resulting in a total of almost 100,000 sq ft in New Castle and Wilmington, DE
1991
Dr. Chuck Beard forms CB Research
Product line includes UV blockers and an extensive catalog of heterocyclic compounds
2005
Adesis forms and acquires the assets of CB Research
2008
First lab expansion in New Castle to 25,000 sq ft
2016
UDC acquires Adesis
2017
Adesis opens new laboratory facility at Delaware Innovation Space in the DuPont Experimental Station
2018
Adesis further expands New Castle labs to 50,000 sq ft
2020
With safety measures in place, Adesis meets customer commitments through the pandemic
2022
Adesis expands at DuPont Experimental Station to >40,000 sq ft, resulting in a total of almost 100,000 sq ft in New Castle and Wilmington, DE
